Erkko Ylösmäki

Person

Latest publications

  1. Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

    Ylösmäki, E., Malorzo, C., Capasso, C., Honkasalo, O., Fusciello, M., Martins, B., Ylösmäki, L., Louna, A., Feola, S., Paavilainen, H., Peltonen, K., Hukkanen, V., Viitala, T. & Cerullo, V., 5 Sep 2018, In : Molecular therapy. 26, 9, p. 2315-2325 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

    Feola, S., Capasso, C., Fusciello, M., Martins, B., Tähtinen, S., Medeot, M., Carpi, S., Frascaro, F., Ylösmaki, E., Peltonen, K., Pastore, L. & Cerullo, V., 2018, In : OncoImmunology. 7, 8, 10 p., 1457596.

    Research output: Contribution to journalArticleScientificpeer-review

  3. ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library

    Gustafsson, M. O., Mohammad, D. K., Ylosmaki, E., Choi, H., Shrestha, S., Wang, Q., Nore, B. F., Saksela, K. & Smith, C. I. E., 3 Apr 2017, In : PLoS One. 12, 4, 13 p., 0174909.

    Research output: Contribution to journalArticleScientificpeer-review

View all (10) »

ID: 33965